Heron Therapeutics Inc. (HRTX)
Symbol Info
Listed Symbol HRTX
Name Heron Therapeutics Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $77,474,000
Latest Fiscal EPS $-2.47
Price Info
21 Day Moving Average $19.1369
21 Day EMA $18.609530
50 Day Moving Average $18.4359
50 Day EMA $18.643960
200 Day EMA $21.093700
200 Day Moving Average 21.375630
52 Week High $31.81
52 Week Low $15.68
52 Week Change $-38.293100
Alpha 0.019959
Beta 1.4099
Standard Deviation 0.206642
R2 0.054960
Periods 60
Share Information
10 Day Average Volume 1,828,982
20 Day Average Volume 1,479,108
30 Day Average Volume 1,237,065
50 Day Average Volume 1,064,154
Outstanding Shares 88,387,846
Float Shares 86,790,105
Percent Float 98.19%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 431
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 11,847,868
Institute Holdings Percent -
Institute Sold Previous 3 Months 10,649,468
Insider Holdings Date
Insider Bought Previous 3 Months -
Insider Holdings Percent -
Insider Sold Previous 3 Months -
Insiders Shares Owned 1,597,741
Price Change
7 Day Price Change $0.4750004
7 Day Percent Change 2.73%
21 Day Price Change $-1.5149994
21 Day Percent Change -7.81%
30 Day Price Change $-2.8449993
30 Day Percent Change -13.72%
Month To Date Price Change $-0.605
Month To Date Percent -3.27%
90 Day Price Change $-0.414999
90 Day Percent Change -2.27%
Quarter To Date $-0.605
Quarter To Date Percent -3.27%
180 Day Price Change $-6.764999
180 Day Percent Change -27.43%
200 Day Price Change $-5.254999
200 Day Percent Change -22.70%
Year To Date $-8.045
Year To Date Percent -31.01%
Profile
Description Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL and CINVANTI. Its pipeline product is HTX-011.
Details
Issue Type CS
Market Cap $1,581,700,504
Sec Type EQS
Auditor OUM & Co. LLP
Total Shares Outstanding 88,387,846
CEO Barry D. Quart
Employees 198
Last Audit UE
Classification
CIK 0000818033
Industry Drug Manufacturers
Sector Healthcare
NAICS Pharmaceutical Preparation Manufacturing(325412)
Info
Address 4242 Campus Point Court
Suite 200
San Diego, CA 92121
Website http://www.herontx.com
Facisimile
Telephone +1 858 251-4400
Email info@herontx.com
Key Ratios
Profitability
EBIT Margin -172.6
EBITDA Margin -171.1
Pre-Tax Profit Margin -
Profit Margin Cont -
Gross Margin 59.20
Profit Margin TOT -
Income Statements
Revenue $97,105,000
Revenue Per Share $1.0986
Revenue 3 Years $-
Revenue 5 Years $-
Valuation Measures
PE Ratio -
Enterprise Value $1,306,513,874
Price To Sales 16.288559
Price To Free Cash -13.8
PE High Last 5 Years -
Price To Book 5.2
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book 5.1
Financial Strength
Total Debt To Equity 0.1
Int Coverage -74.3
Current Ratio 4.0
Leverage Ratio 1.4
Quick Ratio 3.6
Long Term Debt To Capital 0.04
Assets
Receivables Turnover 0.8
Invoice Turnover 1.60
Assets Turnover 0.10
Management Effectiveness
Return Assets -43.62
Return On Equity -54.56
Return On Capital -50.56
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type


Your Recent History
NASDAQ
HRTX
Heron Ther..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.